Skip to content

Randomised placebo-controlled trial of oral doxycycline to reduce recurrent trachomatous trichiasis

Randomised placebo-controlled trial of oral doxycycline to reduce recurrent trachomatous trichiasis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201512001370307
Enrollment
1000
Registered
2015-11-29
Start date
2015-12-14
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

trachomatous trichiasis Surgery Trachomatous trichiasis

Interventions

Doxycycline
Placebo

Sponsors

London School of Hygiene & Tropical Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Trachomatous Trichiasis with tarsal conjunctival scarring 2. Adults (>18 years of age) 3. Agree to be randomly allocated to receive doxycycline or placebo following surgery 4. Agree to re-examination at one week, one, six and twelve months after surgery

Exclusion criteria

Exclusion criteria: 1. Age less than 18 years 2. Pregnant or breast-feeding women 3. Previous eyelid surgery 4. Medically unfit, BP systolic >170, diastolic >110 5. People with known history of hypersensitivity/allergy to Doxycycline or Tetracycline 6. Presence of contra-indication to doxycycline usage o Taking warfarin o Taking sulphonylurea based medication for diabetes o Pre-existing known liver or renal impairment o Myasthenia gravis 7. Patients with trichiasis from other eyelid pathologies, such as: o Blepharitis o Steven Johnson syndrome o Burn o Trauma o Eyelid muscle laxity due to aging o Herpes zoster o Ocular cicatricial pemphigoid

Design outcomes

Primary

MeasureTime frame
Recurrent trichiasis following surgery;Recurrent trichiasis following surgery

Secondary

MeasureTime frame
Severity of recurrent trichiasis;Severity of recurrent trichiasis;Conjunctival inflammation;Change in corneal opacification;Change in visual acuity;Complication Rates;Patient perspectives on the results of surgery;Side effects

Countries

Ethiopia

Contacts

Public ContactEsmael Habtamu

Trial Coordinator

esmael.ali@lshtm.ac.uk+251 915676955

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026